chronic lymphocytic leukaemia Archives -

AbbVie, J&J embed Imbruvica deeper in CLL therapy with new approval

https://pharmaphorum.com/news/abbvie-jj-embed-imbruvica-deeper-in-cll-therapy-with-new-approval/

ASH19: AZ’s Calquence throws gauntlet down to Imbruvica

https://pharmaphorum.com/news/ash19-azs-calquence-throws-gauntlet-down-to-imbruvica/

FDA nod for AZ’s Calquence sets up new Imbruvica showdown

https://pharmaphorum.com/news/fda-nod-for-azs-calquence-sets-up-new-imbruvica-showdown/

AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment

https://pharmaphorum.com/news/az-msd-parp-inhibitor-ovarian-cancer/

AstraZeneca ends another Calquence trial early

https://pharmaphorum.com/news/astrazeneca-ends-another-calquence-trial-early/

TG Therapeutics cancer trial setback sends shares tumbling

https://pharmaphorum.com/news/tg-therapeutics-cancer-trial-setback-sends-shares-tumbling/

Roche/AbbVie drug could further improve prognosis in CLL

https://pharmaphorum.com/news/venetoclax-improve-prognosis-cll-doctor/

Roche/AbbVie combination could raise standards in CLL

https://pharmaphorum.com/news/rocheabbvie-combination-better-chemo-cll/

Leukaemia patients to get access to AbbVie’s Venclyxto via Cancer Drugs Fund

https://pharmaphorum.com/news/cll-patients-england-get-access-abbvies-venclyxto-nice-u-turn/

Search